Floatz logo

18 assets in Li-Fraumeni Syndrome

Therapeutic assets addressing Li-Fraumeni Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cyclophosphamide
Li-Fraumeni Syndrome
Masonic Cancer Center, University of MinnesotaP2B (61)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells
Li-Fraumeni Syndrome
Masonic Cancer Center, University of MinnesotaP2CCC (53)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Li-Fraumeni Syndrome
Masonic Cancer Center, University of MinnesotaP2CCC (53)
Arsenic Trioxide
Li-Fraumeni Syndrome
Yang LiP2CCC (53)
Azacitidine
Li-Fraumeni Syndrome
The First Affiliated Hospital of Xiamen UniversityP2CCC (53)
Busulfanum
Li-Fraumeni Syndrome
Masonic Cancer Center, University of MinnesotaP2CCC (53)
Catequentinib
Li-Fraumeni Syndrome
Tianjin Medical University Cancer Institute and HospitalP2CCC (53)
Famitinib
Li-Fraumeni Syndrome
Tianjin Medical University Cancer Institute and HospitalP2CCC (53)
Fludarabine
Li-Fraumeni Syndrome
Masonic Cancer Center, University of MinnesotaP2CCC (53)
Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)
Li-Fraumeni Syndrome
The First Affiliated Hospital with Nanjing Medical UniversityP2CCC (53)
Lenalidomide
Li-Fraumeni Syndrome
The First Affiliated Hospital with Nanjing Medical UniversityP2CCC (53)
Melphalan
Li-Fraumeni Syndrome
Masonic Cancer Center, University of MinnesotaP2CCC (53)
Obinutuzumab
Li-Fraumeni Syndrome
The First Affiliated Hospital with Nanjing Medical UniversityP2CCC (53)
Rituximab
Li-Fraumeni Syndrome
The First Affiliated Hospital of Xiamen UniversityP2CCC (53)
Bortezomib
Li-Fraumeni Syndrome
Masonic Cancer Center, University of MinnesotaP1/2CC (45)
Cpx-351
Li-Fraumeni Syndrome
Masonic Cancer Center, University of MinnesotaP1/2CC (45)
tp53-epha-2-car-dc
Li-Fraumeni Syndrome
Chinese PLA General HospitalP1CC (43)
Decitabine
Li-Fraumeni Syndrome
Zhejiang UniversityEarly P1C (38)